Drug combination

A composition and drug technology, applied in the directions of drug combinations, active ingredients of heterocyclic compounds, pharmaceutical formulations, etc., can solve the problems of slow onset, short action time, adverse reactions, etc. The effect of quality improvement
CN102049047BActive Publication Date: 2012-07-04SHANDONG NEWTIME PHARMA
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
SHANDONG NEWTIME PHARMA
Publication Date
2012-07-04

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to a drug combination treating male erective dysfunction, in particular to a drug combination containing two foreign medicine active ingredients including Clavulanic acid or salt and phosphodiesterase 5(PDE5) suppressing agents. The combination provided by the invention can overcome the defects of the conventional medicine treating male erective dysfunction such as poor reaction, short action time and slow effect.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a pharmaceutical composition for treating male erectile dysfunction, in particular to a pharmaceutical composition for treating male erectile dysfunction containing two western medicine active ingredients, which belongs to the field of medicine. Background technique

[0002] Erectile dysfunction (Erectile Dysfunction, ED) refers to the continuous (more than 3 months) inability of a man to achieve or maintain a penile erection with sufficient hardness to complete satisfactory sexual intercourse under sexual stimulation. According to statistics, 52% of men aged 40 to 70 have different degrees of ED. It is estimated that by 2025, 322 million men worldwide will have ED problems. Erectile dysfunction often involves multiple systems throughout the body, and the etiology is complex, including vascular, neurological, endocrine, psychological and senile factors, so the clinical efficacy is not ideal.

[0003] There are three main type...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More